Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02688608
Title Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Texas Southwestern Medical Center
Age Groups: adult
Covered Countries USA

No variant requirements are available.